Cargando…
Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
Novel methodological approaches now demonstrate that the unique elastin degradation products desmosine and isodesmosine are detectable in plasma of cystic fibrosis patients and correlate to lung function, exacerbation frequency and disease progression http://bit.ly/2VwZOcx
Autores principales: | Ma, Shuren, Geraghty, Patrick, Dabo, Abdoulaye, McCarthy, Cormac, McElvaney, N. Gerry, Turino, Gerard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571450/ https://www.ncbi.nlm.nih.gov/pubmed/31218219 http://dx.doi.org/10.1183/23120541.00250-2018 |
Ejemplares similares
-
Isotope-dilution LC-MS/MS analysis of the elastin crosslinkers desmosine and isodesmosine in acute cerebral stroke patients
por: Mikagi, Ayame, et al.
Publicado: (2022) -
The effect of tiotropium therapy on markers of elastin degradation in COPD
por: Ma, Shuren, et al.
Publicado: (2009) -
Cation exchange HPLC analysis of desmosines in elastin hydrolysates
por: Perła-Kaján, Joanna, et al.
Publicado: (2011) -
Ultraviolet radiation reduces desmosine cross-links in elastin
por: Dhital, Basant, et al.
Publicado: (2017) -
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
por: McElvaney, Oliver J, et al.
Publicado: (2021)